Ambys Medicines

0 followers


Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities includ... Read more


Org chart

John Choi
VP, Regulatory Affairs
John McKeon
VP, Finance
Stanley Hollenbach
SVP, Pharmacology
Priyadarshini Podishetti
Senior Quality Assurance Engineer
Abeba Demelash Ph.D.
Senior Scientist I
Gabriel Peixoto
Senior Research Associate II
Gaetano ‘Nino’ Faleo
Senior Scientist II
Padma Priya Togarrati, Ph.D., RAPS
Lead Senior Scientist [Bioanalytical]

Board & advisors

Jeff Tong
Director
Holger Willenbring
Scientific Advisor
Daniel P. Anderson
Scientific Advisor
David Russell
Scientific Advisor
Brendan Lee
Scientific Advisor
Yury Popov
Scientific Advisor
Robert Fisher
Clinical Advisor
Raymond Chung
Clinical Advisor
Scott Naugler
Clinical Advisor
Paul Kwo
Clinical Advisor
Stephen Strom
Clinical Advisor
Steven D. Colquhoun
Clinical Advisor
Robert S. Brown Jr.
Clinical Advisor